| Oct 29, 10 | Five GlaxoSmithKline executives who allegedly ignored Eckard believed to be still at company | | No data |
| Oct 28, 10 | Vodafone/Verizon speculation helps lift FTSE 100 | | No data |
| Oct 28, 10 | Standard Chartered up as FTSE holds on to gains | | No data |
| Oct 28, 10 | GlaxoSmithKline whistleblower wins record £61m payout | | No data |
| Oct 27, 10 | GSK whistleblower's reward is money well spent | | No data |
| Oct 27, 10 | GlaxoSmithKline whistleblower awarded $96m payout | | No data |
| Oct 21, 10 | Glaxo blames profits fall on cost-cutting governments and diabetes drug ban | | No data |
| Oct 14, 10 | GSK to donate a billion tablets a year for neglected diseases | | No data |
| Oct 12, 10 | Standard Chartered adds 2% on bid talk, but FTSE dips on economic worries | | No data |
| Sep 24, 10 | Arm and Burberry climb on bid talk as economic data pushes FTSE higher | | No data |
| Sep 24, 10 | Miners lead FTSE lower for fourth day but GlaxoSmithKline recovers | | No data |
| Sep 23, 10 | Mining groups gain on strong metal prices but FTSE falters | | No data |
| Sep 9, 10 | GlaxoSmithKline's medicine man | | No data |
| Sep 6, 10 | GlaxoSmithKline shares hit by call to withdraw Avandia from UK market | | No data |
| Sep 6, 10 | GlaxoSmithKline shares slip on Avandia concerns | | No data |
| Aug 29, 10 | Good Companies Guide: Winners and losers in the corporate sustainability stakes | | No data |
| Aug 20, 10 | Skyepharma slides as US group ends asthma drug deal | | No data |
| Jul 21, 10 | GlaxoSmithKline makes £304m loss | | No data |
| Jul 21, 10 | Apple results and bid hopes lift FTSE for first time in six days | | No data |
| Jul 17, 10 | Diabetes drug 'victory' is really an ugly story about incompetence | | No data |
| Jul 16, 10 | Glaxo's settlement makes the dividend safer – probably | | No data |
| Jul 15, 10 | Glaxo takes £1.57bn legal charge | | No data |
| Jul 15, 10 | FTSE falls on US and China slowdown but Experian shines | | No data |
| Jul 15, 10 | Relief for GlaxoSmithKline as US regulators reject ban on Avandia | | No data |
| Jul 13, 10 | GlaxoSmithKline Avandia FDA | | No data |
| Jul 13, 10 | Glaxo on red alert as FDA scrutinises diabetes drug Avandia | | No data |
| Jul 12, 10 | FTSE heads higher for fifth day as BP bounces back | | No data |
| Jul 9, 10 | Glaxo nervous ahead of Avandia meeting, but FTSE rises for fourth day | | No data |
| Jul 9, 10 | GlaxoSmithKline slips on Avandia investigations | | No data |
| Jul 1, 10 | Swine flu response was £1.2bn well spent, review finds | | No data |